GL1X · GenesisL1 explorer

MolNFT v1 · #146902 · protein

Crystal structure of tryptophan synthase from M. tuberculosis - aminoacrylate- and BRD0059-bound form

6DWE: “Crystal structure of tryptophan synthase from M. tuberculosis - aminoacrylate- and BRD0059-bound form”. X-ray diffraction, 2 ligands (HDJ, CS). MolNFT v1 #146902 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6DWE
Type
protein
Length
2,601 residues
Chains
8
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P9WFY1, P9WFX9
Ligands
HDJ, CS

Structure

x-ray diffraction · 7 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein249—P9WFY1
B—protein405—P9WFX9
G—protein248—P9WFY1
H—protein405—P9WFX9
E—protein246—P9WFY1
F, D—protein400—P9WFX9
C—protein248—P9WFY1

Ligands and binding sites

  • HDJ · (2R,3S,4R)-3-(2',6'-difluoro-4'-methyl[1,1'-biphenyl]-4-yl)-4-(fluoromethyl)azetidine-2-carbonitrile · ligand · 4 copies · chains A, B, G, H, E, F, C, D
  • CS · Cesium ion · metal · 9 copies · chains B, H, D, F
  • FMT · Formic acid · additive · 33 copies · chains A, B, D, F, G, H, E, C
  • MLI · Malonate ion · additive · 4 copies · chains A, G, E, C
  • ACT · Acetate ion · additive · 3 copies · chains A, B, G, H
  • MLA · Malonic acid · additive · 2 copies · chains H, F, D
  • EDO · 1,2-ethanediol · additive · chains B, F
  • PGE · Triethylene glycol · additive · chains D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6DWE · Crystal structure of tryptophan synthase from M. tuberculosis - aminoacrylate- and… · the same entry in another collection · chain A against A, TM-score 1.00
  • P9WFY1 · AlphaFold monomer V2.0 prediction for tryptophan synthase alpha chain (P9WFY1) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.